Get Live Data

Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

  2. Share Prices
  3. Alnylam Pharmac Share Price

Pin to quick picksAlnylam Pharmac Share Price (0HD2)

Alnylam Pharmac Information

Share Price Information for Alnylam Pharmac (0HD2)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 146.34758
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 146.34758
0HD2 Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Alnylam Pharmaceuticals Inc Alnylam Pharmaceuticals Ord Shs

Alnylam Pharmaceuticals Inc Alnylam Pharmaceuticals Ord Shs is listed on the London Stock Exchange trading with ticker code 0HD2.L. It has a market capitalisation of $18.51b, with approximately 126.45m shares in issue. Over the last year, Alnylam Pharmac share price has been traded in a range of 74.788, hitting a high of 215.96873, and a low of 141.18081.

Intraday Alnylam Pharmac Share Chart

Alnylam Pharmac Share Price
Price 146.34758
Bid 0.00
Ask 0.00
Change 0.00 (0.00%)
Volume 0
Open 0.00
High 0.00
Low 0.00
Prev. Close 146.34758

3 Month Alnylam Pharmac Share Graph

Currency USD
Issue Country DE
Shares in Issue 126.45m
Market Capitalisation $18.51b
Market Size 0
52 Week High 215.96873
52 Week High Date 17-Jul-2023
52 Week Low 141.18081
52 Week Low Date 25-Apr-2024
# Trades 0
Vol. Sold 0
Sold Value $N/A
Vol. Bought 0
Bought Value $N/A
PE Ratio -41.57602
Earnings -3.52
Dividend 0.00
Yield 0.00%
Great for
Spread Betting and CFDs
Capital at risk.
Go to site
Great for
0% commission
Other fees apply.
Capital at risk.
Go to site
Great for
Larger Investment Pots
Capital at risk.
Go to site
Great for
Low Fees
Capital at risk.
Go to site

Recent Share Trades for Alnylam Pharmac (0HD2)

Date Time Trade Prc Volume Buy/Sell Bid Ask Value  
26-Apr-2415:04:25145.120Unknown*0.000.000.00O Ordinary
Delayed publication
Was reported as OTC
26-Apr-2415:04:25145.120Unknown*0.000.000.00O Ordinary
Delayed publication
Was reported as OTC
26-Apr-2415:04:25145.120Unknown*0.000.000.00O Ordinary
Delayed publication
Was reported as OTC
26-Apr-2415:04:25145.120Unknown*0.000.000.00O Ordinary
Delayed publication
Was reported as OTC
26-Apr-2415:04:25145.120Unknown*0.000.000.00O Ordinary
Delayed publication
Was reported as OTC
26-Apr-2415:04:25145.120Unknown*0.000.000.00O Ordinary
Delayed publication
Was reported as OTC
26-Apr-2415:04:25145.120Unknown*0.000.000.00O Ordinary
Delayed publication
Was reported as OTC
26-Apr-2415:04:25145.120Unknown*0.000.000.00O Ordinary
Delayed publication
Was reported as OTC
26-Apr-2415:04:25145.120Unknown*0.000.000.00O Ordinary
Delayed publication
Was reported as OTC
26-Apr-2415:04:25145.120Unknown*0.000.000.00O Ordinary
Delayed publication
Was reported as OTC
View more Alnylam Pharmac trades

Directors Deals for Alnylam Pharmac (0HD2)

Announced Traded Action Notifier Price Currency Amount Holding
  • No Directors Deals found.
View more Alnylam Pharmac directors deals
View more Alnylam Pharmac share chat

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.